Glial activation and pathological pain

被引:222
作者
Wieseler-Frank, J [1 ]
Maier, SF [1 ]
Watkins, LR [1 ]
机构
[1] Univ Colorado, Dept Psychol, Ctr Neurosci, Boulder, CO 80309 USA
关键词
astrocyte; microglia; fractalkine; interleukin-1beta; interleukin-6; tumor necrosis factor-alpha; proinflammatory cytokines; pain; review;
D O I
10.1016/j.neuint.2003.09.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pain is a sensation we have all experienced. For most of us, the pain has been temporary. However, for patients with pathological pain, the pain experience is unending, with little hope for therapeutic relief. Pathological pain is characterized by an amplified response to normally innocuous stimuli, and an amplified response to acute pain. Pathological pain has long been described as the result of dysfunctional neuronal activity. While neuronal functioning is indeed altered, there is significant evidence showing that exaggerated pain is regulated by the activation of astrocytes and microglia. In exaggerated pain, astrocytes, and microglia are activated by neuronal signals including substance P, glutamate, and fractalkine. Activation of glia by these substances leads to the release of mediators that then act on other glia and neurons. These include a family of proteins called "proinflammatory cytokines" released from microglia and astrocytes. These cytokines have been shown to be critical mediators of exaggerated pain. Some patients with pathological pain also report "extra-territorial" and/or "mirror" image pain. That is, exaggerated pain is experienced not only in the area of trauma. In extra-territorial pain, pain is also perceived as arising from neighboring healthy tissues outside of the site of trauma. In the rare cases of mirror-image pain, such pain is perceived as arising from the healthy, corresponding body part on the opposite side of the body. New data suggest that activation of astrocyte communication via gap junctions may mediate such spread of pain. While traditional therapies for pathological pain have focused on neuronal targets, the following review describes glia as newly recognized mediators of exaggerated pain, and as new therapeutic targets. Moreover, the glial-neuronal interactions discussed here are likely not exclusive to pain, but rather are likely to play significant roles in other behavioral phenomena. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:389 / 395
页数:7
相关论文
共 71 条
[1]   Tripartite synapses: glia, the unacknowledged partner [J].
Araque, A ;
Parpura, V ;
Sanzgiri, RP ;
Haydon, PG .
TRENDS IN NEUROSCIENCES, 1999, 22 (05) :208-215
[2]   PYROGENS SPECIFICALLY DISRUPT THE ACQUISITION OF A TASK INVOLVING COGNITIVE PROCESSING IN THE RAT [J].
AUBERT, A ;
VEGA, C ;
DANTZER, R ;
GOODALL, G .
BRAIN BEHAVIOR AND IMMUNITY, 1995, 9 (02) :129-148
[3]  
Benveniste Etty N., 1995, P700
[4]   Prostaglandins stimulate calcium-dependent glutamate release in astrocytes [J].
Bezzi, P ;
Carmignoto, G ;
Pasti, L ;
Vesce, S ;
Rossi, D ;
Rizzini, BL ;
Pozzan, T ;
Volterra, A .
NATURE, 1998, 391 (6664) :281-285
[5]   Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage [J].
Chapman, GA ;
Moores, K ;
Harrison, D ;
Campbell, CA ;
Stewart, BR ;
Strijbos, PJLM .
JOURNAL OF NEUROSCIENCE, 2000, 20 (15)
[6]   The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior [J].
Colburn, RW ;
Rickman, AJ ;
DeLeo, JA .
EXPERIMENTAL NEUROLOGY, 1999, 157 (02) :289-304
[7]   Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat [J].
Colburn, RW ;
DeLeo, JA ;
Rickman, AJ ;
Yeager, MP ;
Kwon, P ;
Hickey, WF .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 79 (02) :163-175
[8]   Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model [J].
DeLeo, JA ;
Colburn, RW ;
Nichols, M ;
Malhotra, A .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (09) :695-700
[9]  
Devor M, 1994, TXB PAIN, P79
[10]  
FONTANA A, 1982, J IMMUNOL, V129, P2413